Fifty-one human glycosyltransferases were expressed in Saccharomyces cerevisiae as immobilized enzymes and were assayed for enzymatic activities. The stem and catalytic regions of sialyl-, fucosyl-, galactosyl-, N-acetylgalactosaminyl-, and N-acetylglucosaminyltransferases were fused with yeast cell wall Pir proteins, which anchor glycosyltransferases at the yeast cell wall glucan. More than 75% of expressed recombinant glycosyltransferases retained their enzymatic activities in the yeast cell wall fraction and will be used as a human glycosyltransferase library. In increasing the enzymatic activities of immobilized glycosyltransferases, several approaches were found to be effective. Additional expression of yeast protein disulfide isomerase increased the expression levels and activities of polypeptide N-acetylgalactosaminyltransferases and other glycosyltransferases. PIR3 and/or PIR4 was more effective than PIR1 as a cell wall anchor when the Pirglycosyltransferase fusions were expressed under the control of the constitutive glyceraldehyde-3-phosphate dehydrogenase promoter. Oligosaccharides such as Lewis x, Lewis y, and H antigen were successfully synthesized using this immobilized glycosyltransferase library, indicating that the Pir-fused glycosyltransferases are useful for the production of various human oligosaccharides.
Most oligosaccharides exist as glycoproteins and glycolipids, many of which are localized at the cell surface and are involved in biologically important processes such as cellular adhesion, molecular recognition, and signal transduction (58) . The oligosaccharides are extremely rich in structural variations, and isomers exhibit different branching structures, anomeric configurations, and linkage positions; these vary widely with species, tissue, and degree of cellular differentiation. To clarify the structure-function relationship of oligosaccharides, the synthesis and remodeling of oligosaccharides are required. In order to synthesize complex oligosaccharides on proteins and lipids or in living cells, enzymatic methods are more suitable than chemical methods, since degradation or denaturation of active proteins, lipids, and living cells can be avoided. Human-derived enzymes are particularly ideal for the synthesis of mammalian oligosaccharides, such as sialylated and branched glycans, because these reactions are difficult to reproduce with either chemical methods or bacterial enzymes (19) .
At present, nearly 200 human glycosyltransferase genes are known and are available for use. These are indispensable for enzymatic synthesis of human-type oligosaccharides (41) . However, it is important to make these resources suitable for application as enzyme sources. Immobilized enzymes enable the recovery of valuable enzymes for repeated usage and have several advantages for industrial applications; they are usually more stable than free enzymes and can be applied via automated bioreactor-packed columns.
Glycosyltransferases generally contain a catalytic domain at the C-terminal region and a membrane-spanning region at the N terminus, with which glycosyltransferases are localized at the Golgi membrane. It is also known that many glycosyltransferases are secreted into culture media when the membranespanning region is truncated (4, 5, 33) . Purification of soluble enzymes is laborious, and each enzyme requires a separate protocol for purification from culture broths or cell homogenates. In contrast, immobilization of soluble enzymes to an insoluble carrier by chemical methods is often accompanied by partial loss of enzymatic activity (11, 14, 15) . Glycosyltransferases are generally immobilized at the N-terminal region, whereas the C terminus of glycosyltransferases is very sensitive to modification, since it generally includes the catalytic domain. For example, a single-amino-acid replacement of the C terminus of fucosyltransferase III (FUT3) results in a loss of activity (59) , while the use of site-directed mutagenesis to eliminate glycosylation sites from some glycosylated human glycosyltransferases, such as FUT3, FUT5, FUT6, ␣-2,6-sialyltransferase I (ST6Gal I), and core 2 ␤-1,6-N-acetylglucosaminyltransferase (C2GnT), leads to the loss of enzymatic activity (9, 13, 55) . Although some mammalian glycosyltransferases have been expressed in Escherichia coli, they were often in an insoluble form (6, 16) . On the other hand, yeasts including Saccharomyces cerevisiae and Pichia pastoris, which are unicellular eukaryotic organisms equipped with a protein glycosylation system, are suitable hosts for producing recombinant human glycosyltransferases, provided that reasonable immobilization protocols are developed (5, 20) .
The conventional method for immobilizing proteins on the yeast cell wall was developed using glycosylphosphatidylinositol (GPI) as an anchor to bind proteins onto the ␤-1,6-glucan of the cell wall (39, 46) . However, because the GPI anchor signal sequence is located at the C-terminal end of the precursor proteins (47) , this method is not suitable for the immobilization of glycosyltransferases.
It was recently reported that the yeast S. cerevisiae contains another group of cell wall mannoproteins, Pir (protein with internal repeats), which are covalently bound to the ␤-1,3-glucan of the cell wall in a manner different from that of the GPI anchor (35) . The molecular mechanism of Pir protein binding to the cell wall remains unclear (12, 25) , but Pir protein sequences possess binding potential irrespective of the fusion site, i.e., at either terminus of the target protein (32, 51) . This property is useful for immobilizing glycosyltransferases. In fact, ␣-1,2-galactosyltransferase from the fission yeast Schizosaccharomyces pombe maintained high enzymatic activity when expressed as a fusion protein with Pir in S. cerevisiae, while the same enzyme completely lost enzymatic activity when fused with the GPI anchor signal sequence at the C terminus (1) .
In this study, transmembrane region-truncated forms of various human glycosyltransferases were comprehensively expressed in forms immobilized through the Pir anchor at the yeast cell wall, and their enzymatic activities were analyzed. This analysis indicated that although the expression levels depend on individual enzyme properties, yeast is a suitable host for providing an enzyme source, since more than 75% of the enzymes tested retained their enzyme activities in our yeast cell wall immobilization system.
MATERIALS AND METHODS
Yeast strains, growth media, and genetic methods. We used S. cerevisiae W303-1A strains (MATa leu2-3,112 his3-11 ade2-1 ura3-1 trp1-1 can1-100) (53) in which three of the PIR genes were disrupted: YSF123 (pir1::HisG pir2::HisG pir3::HisG) and YSF124 (pir1::HisG pir2::HisG pir4::HisG). The PDI1 gene was integrated into the HIS3 locus of YSF123 and YSF124 cells and was overexpressed using the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) promoter. SD-Ura medium (49) was used to cultivate yeast cells and to select yeast recombinant transformants. SD medium was maintained at pH 6.0 by addition of HEPES buffer. Yeast transformation was carried out by the lithium acetate method (28) .
Cloning of truncated human glycosyltransferase genes. In order to construct a range of recombinant genes, we used the Gateway system provided by Invitrogen Ltd. (Carlsbad, CA). Truncated glycosyltransferase genes, in which the N-terminal transmembrane region was eliminated, were prepared by PCR using a CACC adaptor sequence at the 5Ј end of the forward primer for the glycosyltransferase genes in order to introduce them into the Gateway entry vector pENTER/D-TOPO. The GalNAc ␣-2,6-sialyltransferase II (ST6GalNAcT II) gene was introduced into the Gateway entry vector pDONOR221. The primer sequences for the truncated glycosyltransferase genes, which were constructed by the authors and M. Nakamura of AIST, are shown in Table 1. Fourteen truncated genes [encoding fucosyltransferases (FUT1, FUT3, FUT6, FUT7, FUT8,  FUT9) , ␣-1,3-galactosyltransferases or N-acetylgalactosaminyltransferases (ABO enzymes), ␤-1,3-and ␤-1,4-galactosyltransferases (␤3GalNAcT1, ␤4GalT4, and ␤4GalT5), i-␤-1,3-N-acetylglucosaminyltransferase (iGnT), and ␤-1,3-N-acetylglucosaminyltransferases (␤3GnT2 and ␤3GnT3)], which were subcloned into the Gateway entry vector, were constructed and provided by M. Nakamura. The remaining 20 truncated genes (␣-2,3-sialyltransferase III [ST3Gal III], ST6GalNAc I, ␤4GalT1, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases [pp- GalNAc-T1, -T2, -T3, -T4, -T6, -T9, -T10, -T12, -T13,  -T14, and -T15] , core 2 ␤-1,6-N-acetylglucosaminyltransferases [C2GnT1, C2GnT2, and C2GnT3], IGnT3, ␤3GnT6, manic fringe [MFNG] , and radical fringe [RFNG] ), which were subcloned into the Gateway entry vector, were kindly provided by H. Narimatsu (22) .
Construction of expression vectors for Pir-glycosyltransferase fusion genes. The expression vectors were based on the YEp352GAP II plasmid, having the URA3 selection marker and the GAPDH promoter. Either the PIR1, PIR3, or PIR4 open reading frame, the hemagglutinin (HA) tag sequence, and Gateway Cassette Frame A were ligated in-frame and inserted into the SacI-SalI site of YEp352GAP II. The glycosyltransferase sequences were inserted using the Gate- Sialyltransferase and galactosyltransferase activities were measured in a 50-l reaction mixture containing the cell wall fraction (optical density at 600 nm [OD 600 ], 5), 100 mM HEPES-NaOH (pH 7.2), 5 mM MnCl 2 , 5 mM CMP-NeuAc or UDP-Gal, and 100 pmol PA-labeled oligosaccharide. In the case of the pp-GalNAc-T assay, the 50-l reaction mixture contained the cell wall fraction (OD 600 , 5), 25 mM HEPES-NaOH (pH 7.2), 5 mM MnCl 2 , 0.25 mM UDPGalNAc, and 500 pmol FITC-labeled Muc5AC peptide. In the case of ␣1,2-and ␣1,3-fucosyltransferases, the reaction mixture contained 50 mM cacodylate buffer (pH 6.8), 12.5 mM MnCl 2 , 5 mM ATP, 0.4 mM GDP-Fuc, and 100 pmol PA-labeled oligosaccharide. The assay of FUT8 was performed as described by Uozumi et al. (57) , and the substrate (GnGn-bi-Asn-PABA) was donated by N. Taniguchi of Osaka University. Reaction mixtures were incubated at 30°C or 37°C for 0.5 to 24 h. The reaction was terminated by adding 100 l of ice-cold water, and the reaction mixture was centrifuged at 1,000 ϫ g for 5 min. The supernatant was filtered through an Ultrafree-MC membrane (pore size, 0.22 m; Millipore, Bedford, MA). A 10-l aliquot of the filtrate was subjected to high-performance liquid chromatography (HPLC) analysis.
HPLC analysis. PA-labeled oligosaccharide products were analyzed by a Shodex Asahipak NH2P-50 normal-phase column (4.6 mm by 250 mm; Showa Denko, Tokyo, Japan) with solvent A (acetonitrile) and solvent B (20 mM acetic acidtriethylamine, pH 7.0) at a flow rate of 1.0 ml/min. After sample injection, the proportion of solvent B was increased linearly for 35 min from 25% to 46%. p-Nitrophenyl (pNP)-labeled sugars were analyzed by a COSMOSIL 5C18-AR-II reverse-phase column (4.6 mm by 250 mm; Nacalai Tesque Inc., Kyoto, Japan) with solvent A (0.05% trifluoroacetic acid) and solvent B (acetonitrile, 0.05% trifluoroacetic acid) at a flow rate of 1.0 ml/min. After sample injection, the proportion of solvent B was increased linearly for 30 min from 10% to 30%. FITC-labeled Muc5AC peptide was analyzed by a COSMOSIL 5C18-AR-II column (4.6 mm by 250 mm) with solvent A (0.05% trifluoroacetic acid) and solvent B (acetonitrile, 0.05% trifluoroacetic acid) at a flow rate of 1.0 ml/min. After sample injection, the proportion of solvent B was increased linearly for 30 min from 10% to 40%. Glycan structures were confirmed by comparison of retention times with PA-labeled standards after suitable glycosidase digestion. Otherwise, the reaction products were analyzed by matrix-assisted laser desorption ionization-time-of-flight tandem mass spectrometry (MALDI-TOF-MS/ MS) (AXIMA-QIT, Shimadzu, Kyoto, Japan) (24) .
Immunofluorescence microscopy. Cells were cultivated for 2 days at 30°C, and a volume of cells equivalent to 1 OD 600 unit was collected. Cells were suspended in 250 l of phosphate-buffered saline (PBS) solution (10 mM KH 2 PO 4 , 40 mM K 2 HPO 4 , 150 mM NaCl) with bovine serum albumin (BSA) (1 mg/ml) and rat anti-HA antibody 3F10 (Boehringer Mannheim, Mannheim, Germany) and were incubated at 4°C for 30 min. Cells were then washed twice in PBS and were incubated in PBS with BSA (1 mg/ml) and Alexa 488-conjugated goat anti-rat immunoglobulin G (IgG) (Molecular Probes, Eugene, OR) (dilution rate, 1:125) at 0°C for 30 min. After a wash, cells were observed under a model BX50 fluorescence microscope (Olympus, Tokyo, Japan).
Flow cytometric analysis. Cells were cultivated in SD medium for 2 days at 30°C, and the cells in 2 ml of culture were washed and resuspended in 0.25 ml of 100 mM PBS (pH 7.4) with 0.1% BSA and 1.25 l anti-HA antibody, followed by incubation at 4°C for 30 min. After two washes with PBS, cells were resuspended in 0.25 ml PBS with 0.1% BSA and 1.25 l anti-rat-IgG-antibody labeled with Alexa 488, followed by incubation at 4°C for 30 min. Cells were washed twice with PBS and sonicated for 2 s to dissociate individual cells; they were then subjected to flow cytometric analysis (FACSCalibur; Nippon Becton Dickinson Co., Ltd., Tokyo, Japan).
Western blot analysis of HA-tagged PIR-glycosyltransferase fusion proteins. Fusion proteins were prepared from cells cultured for 2 days at 30°C. Cells were washed three times in ice-cold wash buffer (10 mM Tris-HCl [pH 8.0], 1 mM phenylmethylsulfonyl fluoride, protease inhibitor Complete [Roche Diagnostics, Mannheim, Germany], EDTA free) and were disrupted by vigorously mixing the cell suspension with glass beads (diameter, 0.45 to 0.5 mm). Cell wall fractions were prepared according to the work of Schreuder et al. (46) with some modifications, after centrifugation of the cell lysates at 1,000 ϫ g for 5 min. Cell wall fractions were washed three times with ice-cold wash buffer, and fusion proteins were extracted according to the method of Mrsa et al. (35) , with slight modifications. The cell wall was extracted by heating the cells twice with 100 l of lysis buffer as described by Masai et al. (31) at 95°C for 10 min, and the remaining cell wall was washed three times with 1 ml of 0.1 M sodium acetate buffer (pH 5.5). Fusion proteins were prepared by extracting the remaining cell wall with 30 mM NaOH overnight at 4°C and were analyzed by Western blotting according to the method of Laemmli (29) . Proteins were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis in a 5-to-20% gradient gel (Atto, Tokyo, Japan) and were transferred to a polyvinylidene difluoride membrane (Pall, East Hills, NJ). HA-tagged fusion proteins were detected with the anti-HA monoclonal antibody HA.11 (Babco, Richmond, CA). Immunoreactive bands were visualized by staining with horseradish-conjugated goat anti-mouse IgG (Cell Signaling Technology, Beverly, MA) and chemiluminescence (NEN Life Science, Boston, MA).
RESULTS
Preparation of yeast cell wall fraction and measurement of glycosyltransferase activity. We selected more than 50 human glycosyltransferase genes that are well characterized and suitable for the synthesis of typical sugar chains attached to glycoproteins. The truncated cDNA clones encoding these glycosyltransferases lacking the N-terminal transmembrane region were inserted into the entry vector of the Gateway system and were then transferred to the destination vector to be expressed in yeast. The truncated glycosyltransferases were placed after the region consisting of yeast cell wall Pir protein and the HA tag sequence; they were expressed under the control of a strong promoter (GAPDH) in Saccharomyces cerevisiae. Fiftyone human glycosyltransferases, including sialyl-, fucosyl-, galactosyl-, N-acetylgalactosaminyl-, and N-acetylglucosaminyltransferases, were expressed in genetically engineered S. cerevisiae strains in which 3 of the 4 PIR genes were disrupted to increase anchoring of the Pir fusion proteins (2) .
Enzymatic activities were measured by HPLC analysis of PA-labeled oligosaccharides, as described in Materials and Methods. Peaks for the acceptor oligosaccharide and reaction products were detected, and the areas of the corresponding peaks were measured. Enzymatic activities were expressed as arbitrary units (1 arbitrary unit ϭ 1 pmol of product/5 OD 600 unit of cell wall/24 h). Under these reaction conditions, when all the acceptor was converted to the product, activity was expressed as Ͼ100 U, because it is technically difficult to examine each enzymatic reaction profile in more detail, and precise analysis of each enzyme was not the goal of this research. Some exceptions indicating more than 100 U were shown for ST3Gal I incubated for 30 min (Table 2) and ppGalNAcT's measured in the presence of 500 pmol of acceptor ( Table 3 ). The specific activity of each enzyme was not determined, since the measurement of the protein amount was difficult for immobilized glycosyltransferases due to incomplete recovery of fusion proteins and the coexistence of endogenous cell wall mannoproteins.
Effect of culture medium pH on enzymatic activity. After yeast cultivation, the pH of the SD-Ura medium generally decreased to below 4. It is possible that yeast proteases, such as GPI-anchored asparagine protease, whose optimal pH is 4.5, are activated and hydrolyze recombinant enzymes, or that the expressed glycosyltransferases are inactivated under acidic conditions. We therefore controlled the pH of the medium during cultivation by addition of HEPES buffer at pH 6. ST3Gal I activity increased from 174 to 706 U (data not shown). The same effect was also observed for ST6Gal I (from VOL
25 to 47 U). Thus, we used these culture conditions for measurement of the remaining glycosyltransferase activities.
Comparison of PIR anchors for immobilization of glycosyltransferases. In our previous study, human glycosyltransferase (FUT6) was fused with PIR1 as an anchor protein (2). However, the PIR family comprises PIR1 to PIR4, with different numbers of 17-to 18-amino-acid repeated sequences, different gene expression regulation mechanisms (36, 54) , and different localizations in the cell wall. Pir1 and Pir2 localize at bud scar regions, whereas Pir3 and Pir4 exist throughout the cell wall (51). To specify a suitable Pir protein for immobilization of glycosyltransferases, glycosyltransferase activities anchored by different Pir sequences were compared. ST3Gal I, anchored by PIR1, PIR3, and PIR4, exhibited activity at 3,917, 4,608, and 4,032 U, respectively ( Fig. 1b; Table 2 ). The amounts of immobilized glycosyltransferases were monitored by flow cytometry after HA tag staining with an HA tag-specific antibody coupled with fluorescence, which revealed much stronger signals for PIR3-anchored cells than for cells anchored by PIR1 or PIR4 (Fig. 1a) . Similarly, FUT1 anchored by PIR3 showed Table 5 ). Furthermore, FUT3, ST3Gal IV, ST6Gal I, and ST6Gal II did not show any activity with the PIR1 fusion, but the PIR3 fusions exhibited enzymatic activity (Table 2) . On the other hand, pp-GalNAc-T3 and -T4 and ␤3GnT2 showed activities only when fused with the PIR4 anchor (Tables 3 and 4 ), suggesting that PIR4 is a suitable anchor protein for the first trial of the immobilized enzyme assay. Therefore, PIR4 was used as an anchor for the expression of further glycosyltransferases. Two types of Pir anchor were used simultaneously for ST3Gal IV, which showed no detectable activity with the PIR1 anchor and low activity (8 U) with the PIR3 anchor (Table 2) . However, when PIR1 and PIR3 fusion proteins were expressed simultaneously, the enzyme activity increased to 30 U, which was much higher than the combined individual activities (Table 2). This result suggests that different kinds of Pir proteins may interact with one another and bind to form a mannoprotein network in the cell wall, resulting in increased immobilization of recombinant enzymes in the cell wall. The PIR gene family is known to have two binding regions for the cell wall. One is the repetitive sequence, which is necessary for binding with ␤1,3-glucan in an alkaline-sensitive manner; the other is the cysteine residue-rich C-terminal region, which is necessary for binding with an unidentified component of the cell wall through the disulfide bond (12, 34, 51) .
Expression of pp-GalNAc-T's and effect of PDI on activity. Many pp-GalNAc-T's expressed in mammalian cells, including pp-GalNAc-T2, -T6, and -T10, have strong activities (8, 22) . However, these enzymes initially showed very low activity when expressed in yeast (Table 3) . When the expression of these immobilized enzymes at the yeast cell wall was examined, the amounts of fusion protein expressed were significantly smaller than those of other glycosyltransferases, as judged from fluorescence microscopic intensity (data not shown) and Western blot analysis (Fig. 2a) . To address the causes of the poor expression of the pp-GalNAc-T family in yeast, we examined the coding sequences of glycosyltransferases. The amino acid sequences of these glycosyltransferases contain about 16 cysteine residues, almost three times as many as other glycosyltransferases. It is possible that the numerous disulfide bonds in pp-GalNAc-T's hinder prompt folding of the proteins, and subsequent production of active enzymes, because yeast cells may lack the capacity to make sufficient disulfide bond. Therefore, protein disulfide isomerase (PDI), a molecular chaperone, was overexpressed in yeast cells. pp-GalNAc-T6 showed a fourfold increase in the protein amount, as judged from the band intensity after probing with an antibody raised against the HA tag, and a comparable increase in activity, as judged from HPLC analysis ( Fig. 2b; Table 3 ). The same effect was also observed for other glycosyltransferases, such as FUT9 (Table  5 ) and ST3Gal IV (data not shown), suggesting that the Pir protein-mediated immobilization of human glycosyltransferases may be adversely affected by protein folding difficulties in the yeast endoplasmic reticulum.
Effect of SED1 or OCH1 gene disruption. SED1 encodes a major GPI-cell wall mannoprotein in stationary-phase yeast cells. Gene disruption of SED1 causes zymolyase sensitivity (50) . Many yeast cell wall proteins, including the Pir family, increase their expression levels during perturbation of cell wall integrity (7, 23) . To investigate whether the elimination of one of the major cell wall mannoproteins induces a compensatory response leading to greater incorporation of Pir proteins into the cell wall, we examined immobilized glycosyltransferase activities in SED1-disrupted cells. As shown in Table 5 , FUT9 and FUT1 activities increased about 1.5-to 2.6-fold as a result of SED1 disruption.
OCH1 encodes ␣-1,6-mannosyltransferase, which is required for the initiation of yeast-specific mannose outer chain elongation of N-glycans (40) . To address whether the large mannose outer chain inhibits glycosyltransferase activities, we examined ST3Gal VI activity. The ST3Gal VI activity of the ⌬och1 cells reproducibly increased about twofold compared with wild-type cells (Table 5 ). However, other enzymes, including ST3Gal I, showed decreased activity in ⌬och1 cells (data not shown). Thus, it is difficult to generalize the effect of yeast-specific polymannosylation on the enzymatic activities of recombinant proteins.
Comprehensive expression of various glycosyltransferases, including N-acetylglucosaminyltransferases and galactosyltransferases. In total, 51 human glycosyltransferase genes were expressed as Pir fusion proteins to mediate localization in the yeast cell wall, and we were successful in detecting enzymatic activity for 40 (see Table 7 ). All fucosyltransferases expressed showed significant activity.
Among the 14 N-acetylglucosaminyltransferases (GnT's), including ␤3GnT2, C2GnT1, N-acetylglucosaminyltransferase V (MGAT5), and MFNG, 12 showed enzymatic activity (Tables   4 and 6 ). ␤3GnT2 is an important enzyme in the synthesis of polylactosamine; however, the enzymatic activity was not very strong in our system (Table 4) . To obtain increased activity, we constructed a variant form of the ␤3GnT2 gene, in which the N-glycosylation site of the C-terminal end was changed from Asn-Leu-Ser (NLS) to Asn-Leu-Thr (NLT), a change reported to increase glycosylation frequency in insect cells (26) . As shown in Table 4 , ␤3GnT2 activity increased about threefold, indicating that this amino acid exchange is useful in improving glycoprotein productivity in both insect cells and yeast cells.
Nine of 13 pp-GalNAc-T's showed some activity (Tables 6  and 7) , although the activity level was relatively low compared with that of other families, probably due to the requirement of more complex disulfide bond formation.
Among the eight galactosyltransferase family proteins (GalT's), ␤4GalT1, ␣-1,3-N-acetylgalactosaminyltransferase [A(ABO)], and ␣-1,3-galactosyltransferase [B(ABO)] showed high activity, low activity was seen for ␤4GalT4 and ␤4GalT5, and no activity was seen for ␤3GalNAcT1, ␤3GalT4, and ␤3GalT5 while these fusion proteins were expressed at the cell wall (Table 6 ). Because these glycosyltransferases use glycolipids or glycopeptides as in vivo acceptors, it is likely that PA-labeled oligosaccharides are not suitable acceptors.
Eight of 10 sialyltransferases showed some activity (Tables 6  and 7) . Pir-mediated ST6GalNAc IV and ST3Gal I fusions had significant activity, indicating that our system has advantages for expressing glycosyltransferases compared with previous reports, in which the soluble form of ST6GalNAc IV was unstable (18, 21) and inactive ST3Gal I was secreted from the yeast Pichia pastoris (48) . ST6GalNAc I and ST6GalNAc II did not show any activity by HPLC analysis when Muc1 peptide-OGalNAc was used as an acceptor, but ST6GalNAc II showed slight activity when tritium-labeled CMP-sialic acid and asialofetuin were used as the donor and acceptor in an enzyme assay (Table 6 ). However, no activity was detected for ST6GalNAc I, even under these assay conditions. ST8Sia VI also showed no enzymatic activity (Table 6) , whereas relatively strong signals were detected for the HAtagged fusion construct (data not shown), suggesting that an unknown cofactor or protein modification may be required for expression of enzymatic activity.
Oligosaccharide synthesis using PIR-mediated fusions of human glycosyltransferases. With the 40-member immobilized human glycosyltransferase library, various types of oligosac- (Tables 2 and 6 ), these enzymes are suitable for the synthesis of several useful oligosaccharides. For example, FUT1 synthesized type 1 and type 2 H antigen from LNnT-PA and LNT-PA, respectively. By using type 2 H antigen as an acceptor, Lewis y oligosaccharide was further synthesized by FUT6 in microgram quantities (Fig.  3) . In another experiment, ST3Gal III synthesized Sia ␣-2,3-Gal ␤1,3-Gn-R and Sia ␣-2,3-Gal ␤1,4-Gn-R from LNnT-PA and LNT-PA, respectively (Table 6 ). MGAT4A and MGAT5 synthesized agalacto-N-triantennary-PA and agalacto-N-tetraantennary-PA oligosaccharides, respectively (Fig. 3) , and C2GnT1 and ␤3GnT6 synthesized core 2 and core 3 oligosaccharides, respectively (Table 6 ). For more practical purposes, acceptors for some glycosyltransferases were synthesized using our immobilized glycosyltransferases. ST6GalNAc IV uses the Sia ␣2,3-Gal ␤1,3-GalNAc-R structure as an acceptor, but this structure is not commercially available. Therefore, we synthesized Sia ␣2,3-Gal ␤1,3-GalNAc ␤1,4-Gal ␤1,4-Glc-PA oligosaccharide from asialo-GM1-tetraose-PA with the immobilized ST3Gal I (Table 2; Fig. 3 ). In addition, pp-GalNAc-T1 shows strong primary activity that transfers a GalNAc residue(s) to peptides, whereas pp-GalNAc-T7 and pp-GalNAc-T9 mainly show secondary activity that transfers a GalNAc residue(s) only to peptides already containing a GalNAc residue(s). Therefore, we first produced Muc5AC-GalNAc by using pp-GalNAc-T1, and then we used Muc5AC-GalNAc purified by HPLC as an acceptor for pp-GalNAc-T7 and pp-GalNAc-T9 (Table 3) .
DISCUSSION
Factors affecting expression of human glycosyltransferases in the yeast cell wall. We attempted to immobilize glycosyltransferases in vivo at the yeast cell surface by fusion with cell wall Pir proteins. After construction of the genetically engineered yeast strains, which express glycosyltransferases that were covalently linked to cell wall glucans, simple cultivation of the yeast cells and centrifugation of the culture broth provided large amounts of immobilized enzymes. A total of 51 human glycosyltransferases were expressed in this study as immobilized proteins, and 40 showed enzymatic activity; more than 75% of human enzymes expressed in yeast were active (Table   TABLE 6 on January 28, 2018 by guest http://aem.asm.org/ 7), indicating that the yeast expression system is useful for the production of large numbers of human glycosyltransferases. In this project, we identified several important factors that affect the amount of immobilized human glycosyltransferase at the yeast cell wall: the choice of Pir anchor proteins, the use of the molecular chaperone PDI, and the codons used, in addition to other factors described above. Comparison of several Pir fusion proteins expressed under the control of the same GAPDH promoter showed higher activities for the PIR3 fusion than for the PIR1 and PIR4 fusions, confirming the more efficient and homogenous localization of PIR3 fusions in the cell wall (51) . Interestingly, a synergistic effect was observed when PIR1 and PIR3 fusions were expressed simultaneously; higher levels of glycosyltransferase activity were observed than the combined activities with PIR1 and PIR3 alone. This suggests that different Pir proteins interact in the yeast cell wall, although the mechanism responsible remains unclear. Furthermore, perturbation of the cell wall architecture by deletion of the major GPI-anchored mannoprotein SED1 (Table 5) or of endogenous Pir proteins (2) increased the amounts of Pirglycosyltransferase fusion proteins.
Eleven glycosyltransferases that we attempted to express in this study showed no detectable activity. Four of these included the pp-GalNAc-T family, in which the presence of many disulfide bonds may inhibit proper protein folding, while some pp-GalNAc-T's retain very weak activity, even in mammalian cells (22) . Among the GalT and GalNAc-T groups, no activity was detected for three enzymes, probably because the PAlabeled oligosaccharides used as acceptors were not suitable for these enzymes. They may recognize glycolipids or glycopeptides in vivo, even if these enzymes are reported to be able to transfer some amounts of sugar to oligosaccharide acceptors in vitro. No activity was detected for ST6GalNAc I or ST8Sia VI, while significant amounts of protein were detected by Western blot analysis. It was reported that unique disulfide bond structures are required for ST8Sia IV activity (3, 10) , suggesting that our PIR4-ST8Sia VI fusion construct disturbs the correct disulfide bond formation of ST8Sia VI protein. For ST8Sia II and ST8Sia IV, it was reported that autopolysialylation is required for activation of the polysialyltransferases (37), suggesting that ST8Sia VI is also activated by autopolysialylation. Alternatively, it is possible that unknown subunits or partners are required for expression of enzymatic activity. In fact, POMT1 and POMT2 are known to form a complex to retain their activities (30) .
The HA tag signal intensity of PIR-HA-glycosyltransferase was often much weaker than that of the PIR-HA anchor, suggesting that the presence of human-derived sequences may inhibit the production of fusion proteins (data not shown). This may be caused by differences in codon usage between humans and yeast. For example, the CGG codon for arginine is the rarest in yeast S. cerevisiae, with a frequency of only 0.17% among all codons (Codon Usage Database [http://www.kazusa .or.jp/codon/]), and is known to inhibit protein translation in yeast (43) , whereas it is more common in humans (frequency, 1.16%). Therefore, it is possible that the low levels of human protein production in yeast are partly due to the presence of rare codons, like CGG, in human genes. The five glycosyltransferases showing strong activity-FUT8, ST3Gal I, ST3Gal III, ␤4GalT1, and pp-GalNAc-T1-contain 0, 5, 6, 6, and 3 CGG codons, respectively, whereas the eight glycosyltransferases showing no activity-ST6GalNAc I, ␤3GalT4, ␤3GalT5, ppGalNAc-T8, -T9, -T14, and -T15, and MGAT3, contain 9, 8, 3, 9, 17, 12, 7, and 3 CGG codons, respectively. This suggests that the increase in rare yeast codons in human genes may decrease the protein productivity and activity of these enzymes.
Although ST3Gal VI increased its enzymatic activity by eliminating hypermannosylation, which may cause the steric hindrance of catalytic sites (Table 5) , other glycosyltransferases, including ST3Gal I, did not increase their activities (data not shown). The och1 gene disruptants generally showed slow growth and weakened cell wall strength (40) , which may reduce amounts of the immobilized Pir fusion proteins.
Oligosaccharide synthesis by recombinant glycosyltransferases. We believe that our system provides a promising approach to synthesizing a variety of oligosaccharides using immobilized human glycosyltransferases. As described above, some useful oligosaccharides, such as H antigen, Lewis x, and Lewis y, were synthesized from LNnT. A and B antigens were (Fig. 3a) . ST3Gal I added sialic acid at the terminal galactose of asialo-GM1-tetraoligosaccharide, and the reaction product was further used as an acceptor for ST6GalNAc IV (Fig. 3b ). MGAT4A and MGAT5 synthesized tri-and tetra-antennary complex N-glycans, respectively (Fig.  3c) , which are useful in the production of N-glycan-engineered erythropoietin (52) . Oligosaccharides or oligosaccharide conjugates inhibit infection by pathogens; for example, GM3 trisaccharide inhibits influenza virus infection (42) , and Oglycans with terminal ␣1,4-linked N-acetylglucosamine inhibit Helicobacter pylori infection (27) . Sialyl Lewis x inhibits inflammation (17, 38, 44, 45) , and GQ1b affects cellular differentiation (56) . A greater variety of oligosaccharides is required for studies on infection, the immune system, cellular differentiation, and cancer. Some of these oligosaccharides will be useful when large-scale production systems are established for the food and medical industries.
